Tilak Mandadi - Nov 30, 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP, Chief DDAT Officer
Signature
/s/ Tilak Mandadi
Stock symbol
CVS
Transactions as of
Nov 30, 2024
Transactions value $
$2,999,981
Form type
4
Date filed
12/3/2024, 05:13 PM
Previous filing
Sep 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock (RSU) Award $3M +50.1K +101.01% $59.85 99.7K Nov 30, 2024 Direct F1
holding CVS Common Stock 40.4K Nov 30, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 96.5K Nov 30, 2024 Common Stock 96.5K $74.31 Direct F2
holding CVS Stock Option 67.9K Nov 30, 2024 Common Stock 67.9K $79.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 11/30/2025.
F2 Option becomes exercisable in four equal annual installments, commencing 4/1/2024.
F3 Option becomes exercisable in four equal annual installments, commencing 4/1/2025.